Category | Insight journal – Company

Salix Pharmaceuticals – Getting to grips with gastrointestinal disorders

Posted on 01 October 2014

Specialty Pharmaceuticals Company Salix Pharmaceuticals is committed to providing treatments for a wide spectrum of gastrointestinal disorders.

Tags: ,

Genmab: Partnering activity 2009-2014

Posted on 29 September 2014

Genmab, a top big biotech company, headquartered in Denmark is one of the leaders today in the human antibody therapeutics market for cancer treatment.

Tags: , ,

Salix Pharmaceuticals: M&A activity 2009 – 2014

Posted on 28 September 2014

Salix Pharmaceuticals has announced 3 M&A deals since 2009, with the deals being the acquisition of Santarus, Oceana Therapeutics and the merger between Salix and Cosmo Pharmaceuticals.

Tags: ,

MorphoSys: Partnering activity 2009-2014

Posted on 22 September 2014

MorphoSys, a leader in antibody drug discovery, has emerged as a top 50 big biotech company with its product pipeline and partnering strategy.

Tags: , ,

Genmab: Rapidly progressing in the field of antibodies

Posted on 19 September 2014

Genmab is an internationally recognised biotechnology company developing human antibody therapeutics primarily for cancer.

Tags: , ,

Isis Pharmaceuticals: Partnering activity 2009-2014

Posted on 15 September 2014

Isis Pharmaceuticals, a leader in antisense drug discovery, has emerged as a top 50 big biotech company with its business strategy.

Tags: , ,

MorphoSys M&A deals 2009-2014

Posted on 12 September 2014

MorphoSys has announced only one acquisition in the past 5 years.

Tags: ,

Jazz Pharmaceuticals – A new entry into the top 50 biotech of 2014

Posted on 08 September 2014

Headquartered in Dublin, Ireland Jazz Pharmaceuticals is a specialty biopharmaceuticals company that has undergone significant growth in recent years. Jazz Pharmaceuticals is focused upon delivering products for cataplexy, narcolepsy, oncology/leukemia, chronic pain and non-opioid schizophrenia.

Tags: , , ,

Isis Pharmaceuticals: So many partnerships, so little time

Posted on 02 September 2014

Isis Pharmaceuticals is an antisense drug discovery technology company developing therapies for a number of serious diseases.

Tags: , , ,

Jazz Pharmaceuticals: M&A activity 2009-2014

Posted on 01 September 2014

Jazz Pharmaceuticals, listed as a new big biotech entrant in 2014, has announced 3 M&A deals since 2009, with the lead deals being the acquisitions of Gentium and merger with Azur Pharma.

Tags: , ,